SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Pharma Science informs about voting results of postal ballot

29 Nov 2024 Evaluate
Strides Pharma Science has informed that the following special resolution has been approved by the Shareholders of the Company with requisite majority by way of remote e-voting: Re-appointment of Dr. Kausalya Santhanam (DIN: 06999168) as an Independent Director of the Company. The above resolution is deemed as passed on November 27, 2024 which was the last date of e-voting for the Postal Ballot. In this connection, the company has enclosed the following: a) Voting Results as required under Regulation 44 of SEBI Listing Regulations as Annexure 1. b) Report of Scrutinizer dated November 29, 2024 pursuant to the Companies Act, 2013 and Rules made thereunder as Annexure 2.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

1000.70 6.80 (0.68%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×